
Tuesday, March 23rd 7:00 p.m. EST.
As a result of participating in this activity, learners will be able to:
- Review historical teachings of primary hyperparathyroidism.
- Explore the evolution of traditional teachings in the era of minimally invasive arathyroidectomy.
- Discuss the appreciation for disease severity in spite of "mild" biochemical presentation and "lack" of symptomatology.
- Review the original NIH criteria and the subsequent revisions.
- Establish a sharpened clinical eye for recognizing the typical presentation in an ambulatory and hospital setting.
The target audience for this presentation: Primary Care Physicians, Endocrinologists and Nephrologists.
CME statement:
USF Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
USF Health designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
USF Health (provider number 2970) is an approved provider of continuing education for nurses through Florida Board of Nursing. This activity has been approved for 1.0 contact hours.
View related document for accreditation information.
CONTACT
If you have any questions or credit related inquiries, please contact USF Health at cpdsupport@usf.edu
Presenters
Douglas E. Politz, MD, FACS, FACE
Senior Parathyroid/Thyroid Surgeon
Co-Founder TGMG Parathyroid & Thyroid Institute
Senior Parathyroid/Thyroid Surgeon
Co-Founder TGMG Parathyroid & Thyroid Institute